Tag: Shockwave Medical

Shockwave completes enrolment in study of coronary intravascular lithotripsy

Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investiga...

Shockwave commences IVL study to support regulatory approval in Japan

Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) ...

Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe

Shockwave Medical, a company which provides intravascular lithotripsy (IVL) to treat complex cal...

Keith Dawkins appointed as chief medical officer at Shockwave Medical

Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release...

A “crackdown” on alternative access for TAVI

  The transfemoral approach is—by far—the most desirable access route for transcatheter ...

Shockwave initiates US pivotal study for coronary intravascular lithotripsy

  Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigatio...

Abiomed invests $15 million in Shockwave Medical

A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two...

Intravascular Lithotripsy for coronary artery disease launched in Europe

Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the mana...

Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver ...